Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
60
ABUS Quote, Financials, Valuation and Earnings
Last price:
$4.78
Seasonality move
:
19.24%
Day range:
$4.70 - $4.91
52-week range:
$2.71 - $5.10
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
62.71x
P/B ratio:
11.90x
Volume:
770.1K
Avg. volume:
1.3M
1-year change:
50.63%
Market cap:
$921.2M
Revenue:
$6.2M
EPS (TTM):
-$0.22
ABUS Analysts' Consensus Rating
The 2 analysts providing 12-month price projections for Arbutus Biopharma Corp. shares anticipate an average target of $5.70, ranging from a low estimate of $5.02 to a high estimate of $6.99. This average target implies a growth of 18.93% compared to the current stock price of $4.79.
Consensus Price Target
$5.70
Highest Price Target
$6.99
Lowest Price Target
$5.02
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 2 | 2 | 2 |
| Hold | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
ABUS Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.92% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.27% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 7.91% over the past day.
